SCHEMBL4308507

SCHEMBL4308507

CN(C)c1ccc(C(N)=S)c2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.53
NEK2 P51955 1/20 0.53
LIMK1 P53667 1/20 0.53
DYRK1A Q13627 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
EP300 Q09472 1/20 0.52
KAT2B Q92831 1/20 0.52
KAT8 Q9H7Z6 1/20 0.52
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
POLB P06746 2/20 0.51
LMNA P02545 1/20 0.51
NFKB1 P19838 1/20 0.51
HTT P42858 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GAA P10253 3/20 0.41
TSHR P16473 2/20 0.41
F2 P00734 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29919884 0.77 CHEK1 (0.73) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL8990307 0.77 CHEK1 (0.73) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL4352832 0.76 MAPT (0.57) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL783395 0.76 MAPT (0.61) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL11708298 0.75 CYP1A2 (0.54) MAPTPOLBGAAALDH1A1KMT2A
SCHEMBL4030721 0.74 MAPT (0.59) CHEK1NEK2LIMK1DYRK1ACLK4
Hydrochloric Acid SCHEMBL27623280 0.74 MAPT (0.59) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL7500203 0.74 GAA (0.54) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL5449088 0.74 MAPT (0.55) CHEK1NEK2LIMK1DYRK1ACLK4
Hydrochloric Acid SCHEMBL27485896 0.74 MAPT (0.51) CHEK1NEK2LIMK1DYRK1ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
WO-2009120826-A1 2-ARYL- AND 2-HETEROARYLTHIAZOLYL COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF WYETH (US) 2009-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof SEC63, SEC62, SEC22B CHEK1 2451/4885NEK2 1104/4885LIMK1 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.